The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) task force has published its Good Practices Report. The purpose of the report is to highlight cost-effectiveness outcomes and to reduce the risk of bias.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR; NJ, USA) has announced the publication of a Good Practices Report on critically appraising the quality and risk of bias – as well as guidance on how to minimize this risk – in systematic reviews that incorporate costs and cost–effectiveness outcomes. The report, alongside an accompanying checklist incorporating the report’s recommendations, was produced by one of the society’s international Task Force groups and appears in Value in Health.” Read more here.
(Source: The Evidence Base, 4/26/21)